Seragon termine l'étude préclinique du candidat d'intervention contre le vieillissement SRN-901

Seragon Biosciences Israel Algeria Bahrain Egypt Iran Iraq Jordan Kuwait Lebanon Libya Morocco Oman Qatar Saudi Arabia Syria Tunisia United Arab Emirates Yemen Angola Botswana Ethiopia Gambia Ghana Guinea-Bissau Kenya Lesotho Liberia Malawi Maldives Mozambique Namibia Nigeria Sierra Leone Somalia South Africa Swaziland Tanzania Uganda Zambia Zimbabwe California

View original content:https://www.prnewswire.com/news-releases/seragon-termine-letude-preclinique-du-candidat-dintervention-contre-le-vieillissement-srn-901-302139105.html